SIF

Oral Communications Abstracts
C5 - Pharmacoepidemiology and Pharmacovigilance


ANTIBIOTICS AND LIVER INJURY IN PAEDIATRIC PRIMARY CARE: A CASE-CONTROL STUDY USING HEALTHCARE DATABASE NETWORK
Ferrajolo C., Verhamme K., Trifirò G., Stricker B., Picelli G., Giaquinto C., Cricelli C., Rossi F., Capuano A., Sturkenboom M.
PAEDIATRIC DRUG USE WITH FOCUS ON OFF-LABEL PRESCRIPTIONS IN LOMBARDY AND IMPLICATIONS FOR THERAPEUTIC APPROACHES
Carnovale C., Conti V., Perrone V., Antoniazzi S., Pozzi M., Merlino L., Venegoni M., Clementi E., Radice S.
DEVELOPMENT AND VALIDATION OF AN ALGORITHM TO APPRAISE THE QUALITY OF SPONTANEOUS REPORTS OF ADVERSE DRUG REACTION: THE QADRA PROJECT
Capogrosso-Sansone A., Tuccori M., Blandizzi C., Rossi M., Gori G., Scarpini F., Mantarro S., Montagnani S., Giustarini G., Vannacci A., Antonioli L., Fornai M., Lapi F.
BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW: EVIDENCE COMING FROM THE ITALIAN POST-MARKETING SURVEILLANCE
Parretta E., Sottosanti L., Sportiello L., Rafaniello C., Potenza S., Colella G., Rossi F., Capuano A.
EFFICACY AND SAFETY OF SECOND-GENERATION ANTIPSYCHOTICS IN PEDIATRIC PATIENTS: A PROGRESS REPORT.
Pozzi M., Auricchio F., Bernardini R., Bertella S., Bravaccio C., Capuano A., Cattaneo D., Ferrajolo C., Fucile S., Molteni M., Pascotto A., Radice S., Rafaniello C., Rizzo R., Sportiello L., Rossi F., Clementi E.
NOVEL INTEGRATED PHARMACOVIGILANCE SCORE TO PRIORITIZE TORSADOGENIC SIGNALS: THE EXPERIENCE OF THE ARITMO PROJECT
Raschi E., Salvo F., Poluzzi E., Moretti U., Chiarolanza A., Suling M., Hazell L., Sturkenboom M., Pariente A., De Ponti F.
PREDICTORS OF MORTALITY IN ATYPICAL ANTIPSYCHOTICS-TREATED COMMUNITY DWELLING ELDERLY PATIENTS WITH BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA: A PROSPECTIVE POPULATION-BASED COHORT STUDY FROM ITALY
Sportiello L., Rafaniello C., Lombardo F., Ferrajolo C., Parretta E., Formica R., Potenza S., Irpino A., Raschetti R., Vanacore N., Rinaldi B., Rossi F., Capuano A.
REGULATION (EC) NO. 1223/2009 ON COSMETIC PRODUCTS ('COSMETICS REGULATION'): THE EUROPEAN COSMETOVIGILANCE SYSTEM. SERIOUS UNDESIRABLE EFFECTS REPORTING GUIDELINES AND NOTIFICATION FORMS
Sautebin L., Fabbri E., D'Alessandro P., Marletta M.